Repaglinide is an antidiabetic drug in the class of medications known as
meglitinides, and was invented in 1983. Repaglinide is an oral medication used
PRANDIN® (repaglinide) is an oral blood glucose-lowering drug of the
meglitinide class used in the management of type 2 diabetes mellitus (also
known as ...
Repaglinide is used to treat type 2 diabetes (condition in which the body does not
use insulin normally and, therefore, cannot control the amount of sugar in the ...
Repaglinide is a nonsulfonylurea insulin secretagogue belonging to the
melgitinide class with hypoglycemic activity. Repaglinide is rapidly absorbed and
has a ...
Medscape - Indication-specific dosing for Prandin (repaglinide), frequency-based
adverse effects, comprehensive interactions, contraindications, pregnancy ...
Jun 13, 2005 ... Repaglinide is an oral antihyperglycemic agent used for the treatment of non-
insulin-dependent diabetes mellitus (NIDDM). It belongs to the ...
Repaglinide lowers blood glucose by encouraging your pancreas to produce
more insulin. It works quickly so is particularly helpful in controlling blood sugar ...
Repaglinide is an antidiabetic drug that belongs to meglitinide category. The
mechanism of action of repaglinide is to lower blood glucose levels by blocking ...
Apr 17, 2015 ... Repaglinide (Prandin) is used to treat people with type 2 diabetes who can't
manage their condition by diet and exercise alone.
Repaglinide tablets are an oral antidiabetic medicine containing repaglinide
which helps your pancreas produce more insulin and thereby lower your blood ...